Viracta Therapeutics Announces Positive Data From the Phase 2 Naval-1 Trial, Regulatory Progress, and Updated Nana-Val Clinical Development Plan
Viracta Therapeutics宣佈海軍-1期試驗獲得積極數據,監管進展及Nana-Val臨床發展計劃更新。
Viracta Therapeutics Announces Positive Data From the Phase 2 Naval-1 Trial, Regulatory Progress, and Updated Nana-Val Clinical Development Plan
Viracta Therapeutics宣佈海軍-1期試驗獲得積極數據,監管進展及Nana-Val臨床發展計劃更新。
譯文內容由第三人軟體翻譯。